跳至主要内容
临床试验/JPRN-jRCTs052180038
JPRN-jRCTs052180038招募中1 期

The safety and efficacy of transcutaneous carbon dioxide (CO2) application for malignant bone and soft tissue tumor (sarcoma) - Transcutaneous carbon dioxide (CO2) application for malignant bone and soft tissue tumor (sarcoma)

Fukase Naomasa0 个研究点目标入组 10 人开始时间: 2019年1月29日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 16age old 至 ot applicable(—)
性别
All

入选标准

  • (1) Patients who have been histologically diagnosed as either malignant bone tumor or malignant soft tissue tumor
  • (2) Age 16 yo or more
  • (3) More than 4 weeks since any prior therapy
  • (4) PS 0-1
  • (5) The patient have consented to the study in the document

排除标准

  • (1) Skin ulcer or pathological fracture in the treated area
  • (2) Peripheral arterial disease or ischemic disease in the affected limb
  • (3) Skin disease in the affected limb
  • (4) Active infectious disease in the affected limb
  • (5) Other medical or psychological unsuitable reasons

研究者

发起方
Fukase Naomasa

相似试验

Transcutaneous carbon dioxide (CO2) application for... | 临床试验